Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis

AAPS PharmSciTech

Volumn 14, Issue 4, 2013, Pages 1284-1293

  Goindi, Shishu ^a   Kumar, Gautam ^a   Kumar, Neeraj ^a   Kaur, Amanpreet ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Atopic dermatitis; Cetirizine; Elastic vesicles; Oxazolone; Topical

Indexed keywords

CETIRIZINE; OXAZOLONE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHISTAMINIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CREAM; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG ANALYSIS; DRUG DIFFUSION; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; EOSINOPHIL COUNT; FRANZ DIFFUSION CELL ASSEMBLY; HUMAN; MALE; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PRURITUS; VISCOSITY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-ALLERGIC AGENTS; CETIRIZINE; CHEMISTRY, PHARMACEUTICAL; DERMATITIS, ATOPIC; DRUG COMPOUNDING; ELASTICITY; ELECTROCHEMISTRY; EXCIPIENTS; FEMALE; HISTAMINE RELEASE; LIPIDS; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; OINTMENTS; PARTICLE SIZE; PHARMACEUTICAL SOLUTIONS; PHOSPHOLIPIDS; SKIN; SKIN ABSORPTION;

EID: 84893690749     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-013-0017-3     Document Type: Article

References (27)

1. Fonacier LS, Dreskin SC, Leung D Y M. Allergic skin diseases. J Allergy Clin Immunol. 2010;125(2):S138-49.
2. Curran MP, Scott LJ, Perry CM. Cetirizine: a review of its use in allergic disorders. Drugs. 2004;64:523-61. doi:10.2165/00003495-200464050-00008.
3. Campoli-Richards D M B, Micaela M-T, Fitton A. Cetirizine: a review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs. 1990;40:762-81.
4. Ousler GW, Wilcox KA, Gupta G, Abelson MB. An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride. Ann Allergy Asthma Immunol. 2004;93:460-4.
5. Walch H, Baden DE. Topical application of cetirizine and loratadine. United State Oramon Arzneimittel GmbH (Laupheim, DE) 6790847;2004. http://www.freepatentsonline.com/6790847.html.
6. Elzainy A A W, Gu X, Simons F E R, Simons KJ. Cetirizine from topical phosphatidylcholine-hydrogenated liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model. AAPS J. 2004;6(3):7-12.
7. Benson H A E. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv. 2006;3:727-37.
8. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Therap Drug Carrier Syst. 1996;13:257-388.
9. Jain S, Jain P, Umamahashwari RB, Jain NK. Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013-26.
10. Cevc G, Blume G, Schatzlein A. Transfersomes-mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J Control Release. 1997;45:211-26.
11. López-Pinto JM, González-Rodríguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm. 2005;298:1-12.
12. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65:403-18.
13. Chuang G C C, Yeh A-I. Rheological characteristics and texture attributes of glutinous rice cakes (mochi). J Food Eng. 2006;74:314-23.
14. Aggarwal N, Goindi S, Mehta SD. Preparation and evaluation of dermal delivery system of griseofulvin containing vitamin E-TPGS as penetration enhancer. AAPS PharmSciTech. 2012;13(1):67-74.
15. El Maghraby G M M, Williams AC, Barry BW. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol. 2001;53:1069-77.
16. Aggarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 2001;228:43-52.
17. Aggarwal N, Goindi S. Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis-dermatophytosis. Int J Pharm. 2012;437:277-87. doi:10.1016.org/j.ijpharm.2012.08.015.
18. Nolte T, Khorasani MZ, Safarov O, et al. Induction of oxazolonemediated features of atopic dermatitis in NOD-scid IL2Rγnull mice engrafted with human peripheral blood mononuclear cells. Dis Model Mech. 2013;6(1):125-34. doi:10.1242/dmm.009167.
19. Man M, Hatano Y, Lee SH, Man M, Chang S, Feingold KR, et al. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol. 2008;128:79-86.
20. Oshio T, Sasaki Y, Funakoshi-Tago M, Aizu-Yokota E, Sonoda Y, Matsuoka H, et al. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment. Int Immunopharmacol. 2009;9:403-11.
21. Trotta M, Peira E, Debernardi F, Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm. 2002;241:319-27.
22. Suwa E, Yamaura K, Oda M, Namiki T, Ueno K. Histamine H4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model. Eur J Pharmacol. 2011;667:383-8.
23. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;36:104-11.
24. Fang JY, Hong CT, Chiu WT, Wang YY. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm. 2001;219:61-72.
25. Gompper G, Kroll DM. Driven transport of fluid vesicles through narrow pores. Phys Rev. 1995; E52:4198-5105.
26. Lichtembery D, Robson RJ, Dennis EA. Solubilization of phospholipid in detergent, structural and kinetic aspects. Biochim Biophy Acta. 2003;737:285-98.
27. Bae S, Tanaka Y, Ogawa F, Takenaka M, Hamazaki Y, Shimizu K, et al. Inhibitory effect of cetirizine on histamine-induced eotaxin production in normal human fibroblasts. Curr Therapeut Res. 2002;63:128-40.